BUTORPHANOL TARTRATE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Butorphanol Tartrate Preservative Free patents expire, and what generic alternatives are available?
Butorphanol Tartrate Preservative Free is a drug marketed by Baxter Hlthcare Corp, Hikma, and Hospira. and is included in five NDAs.
The generic ingredient in BUTORPHANOL TARTRATE PRESERVATIVE FREE is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Butorphanol Tartrate Preservative Free
A generic version of BUTORPHANOL TARTRATE PRESERVATIVE FREE was approved as butorphanol tartrate by HIKMA on August 12th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUTORPHANOL TARTRATE PRESERVATIVE FREE?
- What are the global sales for BUTORPHANOL TARTRATE PRESERVATIVE FREE?
- What is Average Wholesale Price for BUTORPHANOL TARTRATE PRESERVATIVE FREE?
Summary for BUTORPHANOL TARTRATE PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 16 |
Patent Applications: | 1,443 |
DailyMed Link: | BUTORPHANOL TARTRATE PRESERVATIVE FREE at DailyMed |
Pharmacology for BUTORPHANOL TARTRATE PRESERVATIVE FREE
Drug Class | Opioid Agonist/Antagonist |
Mechanism of Action | Competitive Opioid Antagonists Partial Opioid Agonists |